Academic Municipal Hospital Karlsruhe
Department of Nuclear Medicine (590820)
Specialized in: nuclear medicine
About the department
The Department of Nuclear Medicine at the Academic Municipal Hospital Karlsruhe offers the full range of medical services in this field of medicine. The department specializes in modern diagnostic and therapeutic procedures using radionuclide pharmaceuticals. The department cooperates closely with many other departments of the academic hospital. Medical care can be provided both on an inpatient and outpatient basis. The department strictly meets the requirements of radiation protection. The Chief Physician of the department is Prof. Dr. med. Klaus Tatsch.
The department is equipped with advanced diagnostic equipment. It conducts positron emission tomography (PET and PET-CT) with radiopharmaceuticals (F-18 FDG, F-18 FET, Ga-68 DOTA-TATE, Ga-68 PSMA)in order to diagnose diseases of the oncological spectrum, the pathologies of the nervous and cardiovascular systems, scintigraphy of all organs, SPECT and SPECT-CT. It should be noted that the department has a specialized laboratory for quality control of radiopharmaceuticals used for both diagnostics and treatment.
In addition to diagnostic tests, the department's doctors specialize in therapy using special radioisotopes. Also, the specialists have unique competencies in the treatment of benign and malignant thyroid diseases using radioiodine therapy. In addition, the spectrum is complemented by DOTA-TATE Lu-177 radiopeptide therapy for metastatic neuroendocrine tumors, selective internal radiation therapy and other methods.
The department's range of medical services includes:
- Diagnostic methods
- Positron emission tomography (PET)
- PET-CT combined technique
- Whole-body scintigraphy
- Therapeutic methods
- Radioiodine therapy in benign and malignant thyroid diseases
- DOTA-TATE Lu-177 radiopeptide therapy for metastatic neuroendocrine tumors
- Radioligand therapy using PSMA Lu-177 for metastatic prostate cancer
- Selective internal radiation therapy using Y-90 labeled microspheres for primary liver tumors and liver metastases
- Radioimmunotherapy using Y-90 Zevalin for malignant lymphomas
- Palliative treatment of pain syndrome due to bone metastases
- Other diagnostic and therapeutic options
Prof. Klaus Tatsch studied Human Medicine at the Ludwig Maximilian University of Munich. After his doctorate in 1985, he began his professional training in Nuclear Medicine in the Section of Nuclear Medicine in the Department of Radiology, which he graduated in 1990. In 1994, Prof. Tatsch had his habilitation and was appointed as Deputy Head of the Department of Nuclear Medicine. Since 1996 till 2009, he taught as Professor at the Ludwig Maximilian University of Munich.
Since 2009, the doctor has headed the Department of Nuclear Medicine at the Academic Municipal Hospital Karlsruhe. His research focuses include the diagnostics of brain diseases, oncological diagnostics using PET and PET-CT, all innovative treatment techniques using open radionuclides.
Prof. Tatsch is a member of national and international professional societies, for example, the European Association of Nuclear Medicine (EANM). He is a member of the scientific advisory board of the European Journal of Nuclear Medicine and Molecular Imaging and the Quarterly Journal of Nuclear Medicine. In addition, the doctor is a reviewer of other well-known international journals.
Photo of the doctor: (с) Städtisches Klinikum Karlsruhe
Department of Nuclear Medicine.
Academic Municipal Hospital Karlsruhe:
We will be happy to answer all your questions.
thanks for your request.
Within 1 working day, a medical advisor will study your request and contact you by phone (German or your local number will be displayed).
This call is free for you.